Respiratory Medical Associates

23/10/2024

We are pleased to be one of the first to offer Abryvso for prevention of RSV infections in infants for pregnant women

23/07/2024

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that makes it hard to breathe. It includes conditions like emphysema and chronic bronchitis. Learning about COPD, its diagnosis, management, and the latest treatment options can help those affected live healthier, fuller lives.

What is COPD?
COPD causes obstructed airflow from the lungs, leading to symptoms like chronic cough, shortness of breath, and frequent respiratory infections. Smoking is the leading cause, but long-term exposure to irritants like pollution or chemical fumes can also contribute.

Diagnosis
Diagnosing COPD involves a combination of:

Medical History: Discussing symptoms and risk factors, like smoking history.
Physical Exam: Listening to the lungs and checking for signs of COPD.
Spirometry: A lung function test that measures how much air you can inhale and exhale, and how quickly you can exhale.
Imaging Tests: Chest X-rays or CT scans to view the lungs and rule out other conditions.
Arterial Blood Gas Analysis: Measuring oxygen and carbon dioxide levels in the blood to assess lung function.

Management
Managing COPD focuses on relieving symptoms, improving quality of life, and slowing disease progression:

Medications:

Bronchodilators: Relax the muscles around airways.
Steroids: Reduce inflammation.
Antibiotics: Treat infections that can worsen COPD symptoms.
Lifestyle Changes:

Quit Smoking: The most crucial step to prevent further damage.
Healthy Diet: Proper nutrition supports overall health.
Exercise: Enhances lung function and overall well-being.
Pulmonary Rehabilitation: A program combining exercise, education, and support to improve breathing and activity levels.

Oxygen Therapy: For those with severe COPD and low blood oxygen levels.

Surgery: In severe cases, procedures like lung volume reduction surgery or a lung transplant may be options.

New Treatment Options
Recent advancements in COPD treatment offer hope:

Triple Therapy Inhalers: Combining three types of medications in one inhaler for more effective symptom control.
Biologic Therapies: Targeting specific pathways involved in inflammation and airway constriction.
Endobronchial Valve Therapy: A minimally invasive procedure where tiny valves are placed in the airways to redirect airflow and improve lung function.

Living with COPD
Living with COPD can be challenging, but with the right approach and support, you can manage the condition effectively. Regular check-ups, adhering to treatment plans, and making healthy lifestyle choices are key. Stay informed about new treatment options and advancements that could benefit you.

Support and Resources
Don't face COPD alone. Seek support from healthcare providers, join support groups, and access resources from organizations like the American Lung Association and COPD Foundation.

Remember, managing COPD is a journey, and every step you take towards better health makes a difference. Stay proactive, stay informed, and stay connected to your healthcare team.

09/06/2024

We are proud to be one of the first providers of the RSV Vaccine in Singapore

Respiratory Syncytial Virus (RSV) is a common and highly contagious virus that affects the respiratory tract. It's a significant cause of respiratory illness in people of all ages, but it can be especially serious for infants, young children, older adults, and those with weakened immune systems. Here’s what you need to know about RSV and how you can protect your loved ones.

🔍 What is RSV?
RSV is a virus that causes infections of the lungs and respiratory tract. While it often presents with mild, cold-like symptoms in healthy adults and older children, it can lead to severe conditions such as bronchiolitis and pneumonia in infants and the elderly.

🤒 Symptoms to Watch Out For:

Runny nose
Decrease in appetite
Coughing
Sneezing
Fever
Wheezing
For infants, symptoms may include irritability, decreased activity, and breathing difficulties.

👶 Who is at Risk?

Infants, especially those born prematurely
Young children with congenital heart or chronic lung disease
Children and adults with weakened immune systems
Older adults, particularly those with underlying health conditions
💉 Prevention and Vaccination:
Good news! A new RSV vaccine is now available and can significantly reduce the risk of severe illness caused by RSV. Here’s what you should know about the vaccine:

Who Should Get Vaccinated?

Infants (the vaccine can be given to pregnant women in their third trimester to help protect their newborns).
Older adults, especially those 60 years and older.
Individuals with underlying health conditions.
Effectiveness:

The vaccine has shown to be highly effective in preventing severe RSV-related illnesses and hospitalizations.
Safety:

Clinical trials have demonstrated the safety of the RSV vaccine with mild side effects, such as soreness at the injection site and low-grade fever, being the most common.
🛡️ Other Preventive Measures:

Wash your hands frequently with soap and water.
Avoid close contact with sick individuals.
Clean and disinfect surfaces regularly.
Keep infants away from crowded places during RSV season (fall, winter, and early spring).

09/06/2024

We are proud to be one of the first few providers of the RSV Vaccine in Singapore

Respiratory Syncytial Virus (RSV) is a common and highly contagious virus that affects the respiratory tract. It's a significant cause of respiratory illness in people of all ages, but it can be especially serious for infants, young children, older adults, and those with weakened immune systems. Here’s what you need to know about RSV and how you can protect your loved ones.

🔍 What is RSV?
RSV is a virus that causes infections of the lungs and respiratory tract. While it often presents with mild, cold-like symptoms in healthy adults and older children, it can lead to severe conditions such as bronchiolitis and pneumonia in infants and the elderly.

🤒 Symptoms to Watch Out For:

Runny nose
Decrease in appetite
Coughing
Sneezing
Fever
Wheezing
For infants, symptoms may include irritability, decreased activity, and breathing difficulties.

👶 Who is at Risk?

Infants, especially those born prematurely
Young children with congenital heart or chronic lung disease
Children and adults with weakened immune systems
Older adults, particularly those with underlying health conditions
💉 Prevention and Vaccination:
Good news! A new RSV vaccine is now available and can significantly reduce the risk of severe illness caused by RSV. Here’s what you should know about the vaccine:

Who Should Get Vaccinated?

Infants (the vaccine can be given to pregnant women in their third trimester to help protect their newborns).
Older adults, especially those 60 years and older.
Individuals with underlying health conditions.
Effectiveness:

The vaccine has shown to be highly effective in preventing severe RSV-related illnesses and hospitalizations.
Safety:

Clinical trials have demonstrated the safety of the RSV vaccine with mild side effects, such as soreness at the injection site and low-grade fever, being the most common.
🛡️ Other Preventive Measures:

Wash your hands frequently with soap and water.
Avoid close contact with sick individuals.
Clean and disinfect surfaces regularly.
Keep infants away from crowded places during RSV season (fall, winter, and early spring).

08/02/2024

Spending a day learning about cryobiopsy as an adjunct to bronchoscopy. As physicians, it is imperative that we remain vigilant in keeping abreast of the latest techniques and advancements in our field. Staying current ensures that we can provide our patients with the highest standard of care, incorporating innovative approaches that may lead to improved outcomes and better patient experiences. By continually expanding our knowledge and skill set, we uphold our commitment to delivering optimal healthcare and staying at the forefront of medical practice.

Cryobiopsy: A Cutting-Edge Procedure for Lung Patients 🫁

Lung patients, take note! Cryobiopsy is revolutionizing diagnostic procedures, offering enhanced benefits compared to traditional methods. This advanced technique involves the use of a specialized probe that rapidly freezes and extracts tissue samples from the lungs. Here's why it's gaining traction:

Increased Accuracy: Cryobiopsy provides larger and more intact tissue samples, allowing for more precise diagnosis compared to traditional biopsy methods. This accuracy is crucial in determining the appropriate treatment plan for lung conditions.

Improved Recovery Time: The less invasive nature of cryobiopsy typically results in shorter hospital stays and quicker recovery times for patients, allowing them to resume their daily activities sooner.

Enhanced Diagnostic Yield: By obtaining larger tissue samples, cryobiopsy increases the likelihood of identifying specific lung conditions, leading to more targeted and effective treatment strategies.

In conclusion, cryobiopsy stands out as a valuable tool in the arsenal of diagnostic procedures for lung patients, offering increased accuracy, minimized complications, quicker recovery, and improved diagnostic yield. Stay informed and explore this innovative option with your healthcare provider for a comprehensive approach to managing lung health. Healthcare Group 🫁

19/01/2024

Good article regarding screening for cancer

Recounting the roller-coaster of emotions she felt after finding out her lump was malignant, she now urges women to be proactive about cancer screening. Read more at straitstimes.com.

12/01/2024

🌟 𝗣𝗿𝗶𝗼𝗿𝗶𝘁𝗶𝘇𝗲 𝗬𝗼𝘂𝗿 𝗛𝗲𝗮𝗹𝘁𝗵: 𝗟𝘂𝗻𝗴 𝗖𝗮𝗻𝗰𝗲𝗿 𝗦𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴 𝗔𝗻𝗱 𝗥𝗶𝘀𝗸𝘀 🌬️

Hey everyone! 👋 As we navigate through life, it's crucial to prioritize our health and well-being. Today, let's shed light on an important topic that affects many lives: Lung Cancer. 🫁

𝗪𝗵𝘆 𝗟𝘂𝗻𝗴 𝗖𝗮𝗻𝗰𝗲𝗿 𝗦𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴? 🤔

Lung cancer, often diagnosed at advanced stages, can be more effectively treated when detected early. That's where screening comes in! Regular lung cancer screenings can catch potential issues before symptoms appear, providing a greater chance for successful intervention. At Respiratory Medical Associates, we run a lung cancer screening program

𝗧𝗵𝗲 𝗥𝗶𝘀𝗸𝘀: 𝗬𝗼𝘂 𝗡𝗲𝗲𝗱 𝗧𝗼 𝗞𝗻𝗼𝘄! 🚭🌳

1️⃣ Smoking: The primary cause of lung cancer. If you smoke, quitting is the single best thing you can do for your lung health.

2️⃣ Secondhand Smoke: Even if you don't smoke, exposure to secondhand smoke can increase your risk.

3️⃣ Radon Exposure: Radon, a colorless, odorless gas, can be found in homes and poses a risk if levels are high.

4️⃣ Occupational Exposures: Some jobs involve exposure to carcinogens like asbestos and certain chemicals, increasing the risk.

𝗛𝗼𝘄 𝗖𝗮𝗻 𝗬𝗼𝘂 𝗛𝗲𝗹𝗽? 🌈

1️⃣ 𝗦𝗵𝗮𝗿𝗲 𝘁𝗵𝗶𝘀 𝗽𝗼𝘀𝘁: You might save a life by spreading awareness. Share this post!

2️⃣ 𝗟𝗲𝗮𝗿𝗻 𝗮𝗯𝗼𝘂𝘁 𝗦𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴: Understand the benefits and discuss with your healthcare provider if you are at risk.

3️⃣ 𝗤𝘂𝗶𝘁 𝗦𝗺𝗼𝗸𝗶𝗻𝗴: If you smoke, take steps to quit. There are numerous resources available to help.

4️⃣ 𝗘𝗻𝗰𝗼𝘂𝗿𝗮𝗴𝗲 𝗢𝘁𝗵𝗲𝗿𝘀: Advocate for policies that reduce to***co use and protect people from secondhand smoke.

Let's come together in the fight against lung cancer! 💙 Your health matters, and early detection can save lives. Share this information, encourage screenings, and let's take a step towards a healthier future! 🌟

12/01/2024

Asia’s Lung Centre For Respiratory Health O2 LUNG CENTRE FIND OUT MORE About O2 Lung Centre Reshaping Lung Care In Asia At O2 Healthcare Group , our team of trained lung specialists is dedicated to delivering exceptional care, focusing on enhancing the quality of life for our patients. With expert...

04/07/2023

We are proud to partner with to offer state of the art cancer screening for our patients

27/04/2023

支气管哮喘是一种常见的慢性呼吸系统疾病，它的发病机制复杂多样，临床表现不一。近年来，随着研究的深入，支气管哮喘的治疗策略也不断更新，其中包括以下方面：

个体化治疗
支气管哮喘患者的症状、病因和治疗反应存在很大差异，因此个体化治疗是当前的研究热点。针对不同的患者，医生需要综合考虑患者的年龄、症状、哮喘程度等因素，制定个性化的治疗方案，以达到最佳治疗效果。

生物制剂治疗
生物制剂是指利用生物技术生产的具有特异性作用的药物，例如抗体、蛋白质等。近年来，生物制剂治疗在支气管哮喘治疗中得到了广泛应用。目前，生物制剂主要用于难治性支气管哮喘的治疗，包括抗IL-5治疗和抗IL-4/13治疗等。

总之，随着支气管哮喘治疗的不断更新，个体化治疗和生物制剂治疗等新方法的应用，将会为支气管哮喘患者带来更好的治疗效果和生活质量。

Regenerate response

27/03/2023

Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), is a term used to describe a range of symptoms that persist for weeks or months after the acute phase of COVID-19. While long COVID can affect multiple organs, it is increasingly being recognized that the lungs are one of the most commonly affected organs in patients with long COVID.

Symptoms of long COVID affecting the lungs can include shortness of breath, chest pain, cough, wheezing, and fatigue. Some patients may also experience a persistent cough, which can be productive or non-productive. These symptoms can be debilitating and can significantly impact a patient's quality of life.

Diagnosis of long COVID affecting the lungs is often challenging as patients may not have any abnormal findings on routine lung function tests or imaging studies. However, some patients may have evidence of pulmonary fibrosis, a condition characterized by scarring of the lung tissue, on high-resolution CT scans. Other diagnostic modalities, such as pulmonary function tests and exercise testing, may be useful in evaluating the extent of lung damage and functional impairment in these patients.

Currently, there is no specific treatment for long COVID affecting the lungs, and management is largely supportive. Pulmonary rehabilitation, including exercise training and breathing exercises, may help improve lung function and alleviate symptoms. Other supportive measures, such as supplemental oxygen therapy, bronchodilators, and corticosteroids, may also be considered in selected patients based on their clinical presentation.

In addition to supportive measures, several ongoing clinical trials are evaluating the efficacy of novel therapies for long COVID. These include antiviral agents, immunomodulatory agents, and monoclonal antibodies targeting various pathways involved in the pathogenesis of long COVID.

In conclusion, long COVID affecting the lungs is a complex and challenging condition that can significantly impact a patient's quality of life. While supportive measures remain the cornerstone of management, ongoing research is needed to identify effective therapies for these patients.

We, at Respiratory Medical Associates, are currently running a Long COVID screening programme and provide treatment and rehabilitation services. Please see us if you suspect you may have such issues

References:

Nalbandian A, Sehgal K, Gupta A, et al. Post-Acute COVID-19 Syndrome. Nat Med. 2021;27(4):601-615.

Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220-232.

Marshall M. The lasting misery of coronavirus long-haulers. Nature. 2020;585(7825):339-341.

Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4-e6.

Ramakrishnan S, Nicolau DV Jr, Langford B, et al. Inhaled budesonide in the treatment of early COVID-19 illness: a randomized controlled trial. medRxiv. 2021.